TD Cowen on Merck (MRK): 'Enflonsia ACIP Vote Could Unlock Significant Potential'

TD Cowen analyst Steve Scala reiterated a Hold rating and $100.00 price target on Merck (NYSE: MRK).

The analyst commented: "Enflonsia ACIP Vote Could Unlock Significant Potential;

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $78.83 yesterday.

You May Also Be Interested In

• Morgan Stanley Upgrades Merck (MRK) to Overweight
• Baird Starts Covenant Logistics Group Inc. (CVLG) at Outperform
• Ck Hutch Seeks Over $1.5b For Destruction Of Panama Investments - Bloomberg